Corporate Headquarters : 21 Firstfield Road, Gaithersburg, MD 20878, USA
Phone (240) 268-2000
Website : www.novavax.com
NovavaxAB : Kungsgatan, 109, SE- 753 18 Uppsala, Sweden
Phone +46 (0) 18 16 17 00
NovavaxPRAHA : Bohumil 138, 281 63 Jevany, Czech Republic
Phone +420 321 616 426
Investor Relations and Media : (240) 268-2022
ir@novavax.com
Employment Opportunities : (240) 268-2000
Business Development Queries : busdev@novavax.com
Who is Novavax?
We are a late-stage biotechnology company that promotes improved global health through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
We have more than a decade of experience contending with some of the world’s most devastating diseases, including COVID-19, seasonal influenza, RSV, Ebola, MERS, and SARS. Hard-won lessons and significant advances illustrate that our proven technology has tremendous potential to make a substantial contribution to public health worldwide.
Our vaccine candidates are genetically engineered using three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis.
We are also developing proprietary immune-stimulating saponin-based adjuvants at Novavax AB, our wholly owned Swedish subsidiary. Matrix-M™ has been shown to enhance immune responses and has been well tolerated in multiple clinical trials.
Comments